162 related articles for article (PubMed ID: 35918447)
1. PILRA polymorphism modifies the effect of APOE4 and GM17 on Alzheimer's disease risk.
Lopatko Lindman K; Jonsson C; Weidung B; Olsson J; Pandey JP; Prokopenko D; Tanzi RE; Hallmans G; Eriksson S; Elgh F; Lövheim H
Sci Rep; 2022 Aug; 12(1):13264. PubMed ID: 35918447
[TBL] [Abstract][Full Text] [Related]
2. The PILRA G78R Variant Correlates with Higher HSV-1-Specific IgG Titers in Alzheimer's Disease.
Agostini S; Costa AS; Mancuso R; Guerini FR; Nemni R; Clerici M
Cell Mol Neurobiol; 2019 Nov; 39(8):1217-1221. PubMed ID: 31297637
[TBL] [Abstract][Full Text] [Related]
3. Protective effect of apolipoprotein E epsilon 3 on sporadic Alzheimer's disease in the Chinese population: a meta-analysis.
Chen Q; Wang T; Kang D; Chen L
Sci Rep; 2022 Aug; 12(1):13620. PubMed ID: 35948759
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory Fcγ Receptor and Paired Immunoglobulin Type 2 Receptor Alpha Genotypes in Alzheimer's Disease.
Pandey JP; Namboodiri AM; Nietert PJ; Barnes LL; Bennett DA
J Alzheimers Dis; 2021; 84(3):965-968. PubMed ID: 34602489
[TBL] [Abstract][Full Text] [Related]
5. Association of Uncommon, Noncoding Variants in the APOE Region With Risk of Alzheimer Disease in Adults of European Ancestry.
Blue EE; Cheng A; Chen S; Yu CE;
JAMA Netw Open; 2020 Oct; 3(10):e2017666. PubMed ID: 33090224
[TBL] [Abstract][Full Text] [Related]
6. Whole-exome sequencing of the BDR cohort: evidence to support the role of the PILRA gene in Alzheimer's disease.
Patel T; Brookes KJ; Turton J; Chaudhury S; Guetta-Baranes T; Guerreiro R; Bras J; Hernandez D; Singleton A; Francis PT; Hardy J; Morgan K
Neuropathol Appl Neurobiol; 2018 Aug; 44(5):506-521. PubMed ID: 29181857
[TBL] [Abstract][Full Text] [Related]
7. Apolipoprotein E-epsilon4 alleles in cerebral amyloid angiopathy and cerebrovascular pathology associated with Alzheimer's disease.
Premkumar DR; Cohen DL; Hedera P; Friedland RP; Kalaria RN
Am J Pathol; 1996 Jun; 148(6):2083-95. PubMed ID: 8669492
[TBL] [Abstract][Full Text] [Related]
8. Association of CD33 rs3865444:C˃A polymorphism with a reduced risk of late-onset Alzheimer's disease in Slovaks is limited to subjects carrying the APOE ε4 allele.
Javor J; Ďurmanová V; Párnická Z; Minárik G; Králová M; Pečeňák J; Vašečková B; Režnáková V; Šutovský S; Gmitterová K; Hromádka T; Peterajová Ľ; Shawkatová I
Int J Immunogenet; 2020 Oct; 47(5):397-405. PubMed ID: 32333488
[TBL] [Abstract][Full Text] [Related]
9. The SIRT2 polymorphism rs10410544 and risk of Alzheimer's disease in two Caucasian case-control cohorts.
Polito L; Kehoe PG; Davin A; Benussi L; Ghidoni R; Binetti G; Quadri P; Lucca U; Tettamanti M; Clerici F; Bagnoli S; Galimberti D; Nacmias B; Sorbi S; Guaita A; Scarpini E; Mariani C; Forloni G; Albani D
Alzheimers Dement; 2013 Jul; 9(4):392-9. PubMed ID: 22651940
[TBL] [Abstract][Full Text] [Related]
10. Association between apolipoprotein E polymorphism and Alzheimer disease in Tehran, Iran.
Raygani AV; Zahrai M; Raygani AV; Doosti M; Javadi E; Rezaei M; Pourmotabbed T
Neurosci Lett; 2005 Feb; 375(1):1-6. PubMed ID: 15664112
[TBL] [Abstract][Full Text] [Related]
11. Apolipoprotein E gene polymorphism and Alzheimer's disease in Chinese population: a meta-analysis.
Liu M; Bian C; Zhang J; Wen F
Sci Rep; 2014 Mar; 4():4383. PubMed ID: 24632849
[TBL] [Abstract][Full Text] [Related]
12. Association between selected cholesterol-related gene polymorphisms and Alzheimer's disease in a Turkish cohort.
Guven G; Vurgun E; Bilgic B; Hanagasi H; Gurvit H; Ozer E; Lohmann E; Erginel-Unaltuna N
Mol Biol Rep; 2019 Apr; 46(2):1701-1707. PubMed ID: 30684189
[TBL] [Abstract][Full Text] [Related]
13. APOE ε4 allele elevates the expressions of inflammatory factors and promotes Alzheimer's disease progression: A comparative study based on Han and She populations in the Wenzhou area.
Fan YY; Cai QL; Gao ZY; Lin X; Huang Q; Tang W; Liu JH
Brain Res Bull; 2017 Jun; 132():39-43. PubMed ID: 28461186
[TBL] [Abstract][Full Text] [Related]
14. APOE epsilon 4 lowers age at onset and is a high risk factor for Alzheimer's disease; a case control study from central Norway.
Sando SB; Melquist S; Cannon A; Hutton ML; Sletvold O; Saltvedt I; White LR; Lydersen S; Aasly JO
BMC Neurol; 2008 Apr; 8():9. PubMed ID: 18416843
[TBL] [Abstract][Full Text] [Related]
15. The association between the ApoE polymorphisms and the MRI-defined intracranial lesions in a cohort of southern China population.
Li Z; Yang N; Lei X; Lin C; Li N; Jiang X; Wei X; Xu B
J Clin Lab Anal; 2019 Sep; 33(7):e22950. PubMed ID: 31199015
[TBL] [Abstract][Full Text] [Related]
16. Apolipoprotein E gene in physiological and pathological aging.
Ferri E; Gussago C; Casati M; Mari D; Rossi PD; Ciccone S; Cesari M; Arosio B
Mech Ageing Dev; 2019 Mar; 178():41-45. PubMed ID: 30658061
[TBL] [Abstract][Full Text] [Related]
17. Apolipoprotein E genotype and the diagnostic accuracy of cerebrospinal fluid biomarkers for Alzheimer disease.
Lautner R; Palmqvist S; Mattsson N; Andreasson U; Wallin A; Pålsson E; Jakobsson J; Herukka SK; Owenius R; Olsson B; Hampel H; Rujescu D; Ewers M; Landén M; Minthon L; Blennow K; Zetterberg H; Hansson O;
JAMA Psychiatry; 2014 Oct; 71(10):1183-91. PubMed ID: 25162367
[TBL] [Abstract][Full Text] [Related]
18. Cholesteryl ester transfer protein (CETP) polymorphism modifies the Alzheimer's disease risk associated with APOE epsilon4 allele.
Rodríguez E; Mateo I; Infante J; Llorca J; Berciano J; Combarros O
J Neurol; 2006 Feb; 253(2):181-5. PubMed ID: 16096813
[TBL] [Abstract][Full Text] [Related]
19. A haptoglobin (HP) structural variant alters the effect of APOE alleles on Alzheimer's disease.
Bai H; Naj AC; Benchek P; Dumitrescu L; Hohman T; Hamilton-Nelson K; Kallianpur AR; Griswold AJ; Vardarajan B; Martin ER; Beecham GW; Below JE; Schellenberg G; Mayeux R; Farrer L; Pericak-Vance MA; Haines JL; Bush WS;
Alzheimers Dement; 2023 Nov; 19(11):4886-4895. PubMed ID: 37051669
[TBL] [Abstract][Full Text] [Related]
20. Low density lipoprotein receptor-related protein gene polymorphisms and risk for late-onset Alzheimer's disease in a Japanese population.
Hatanaka Y; Kamino K; Fukuo K; Mitsuda N; Nishiwaki-Ueda Y; Sato N; Satoh T; Yamamoto H; Yoneda H; Imagawa M; Miki T; Ohta S; Ogihara T
Clin Genet; 2000 Oct; 58(4):319-23. PubMed ID: 11076057
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
